Safety	safety	O	O
of	of	O	O
transesophageal	transesophageal	O	O
echocardiography	echocardiography	O	O
in	in	O	O
adults	adults	O	O
:	:	O	O
study	study	O	O
in	in	O	O
a	a	O	O
multidisciplinary	multidisciplinary	O	O
hospital	hospital	O	O
.	.	O	O

BACKGROUND	background	O	O
:	:	O	O
TEE	tee	O	O
is	is	O	O
a	a	O	O
semi-invasive	semi-invasive	O	O
tool	tool	O	O
broadly	broadly	O	O
used	used	O	O
and	and	O	O
its	its	O	O
utilization	utilization	O	O
associated	associated	O	O
to	to	O	O
sedatives	sedatives	O	O
drugs	drugs	O	O
might	might	O	O
to	to	O	O
affect	affect	O	O
the	the	O	O
procedure	procedure	O	O
safety	safety	O	O
.	.	O	O

OBJECTIVE	objective	O	O
:	:	O	O
to	to	O	O
analyze	analyze	O	O
aspects	aspects	O	O
of	of	O	O
TEE	tee	O	O
safety	safety	O	O
associated	associated	O	O
to	to	O	O
the	the	O	O
use	use	O	O
of	of	O	O
Midazolan	midazolan	S_chemical	O
(	(	O	O
MZ	mz	S_chemical	O
)	)	O	O
and	and	O	O
Flumazenil	flumazenil	S_chemical	O
(	(	O	O
FL	fl	O	O
)	)	O	O
and	and	O	O
the	the	O	O
influence	influence	O	O
of	of	O	O
the	the	O	O
clinical	clinical	O	O
variables	variables	O	O
on	on	O	O
the	the	O	O
event	event	O	O
rate	rate	O	O
.	.	O	O

METHOD	method	O	O
:	:	O	O
prospective	prospective	O	O
study	study	O	O
with	with	O	O
137	137	O	O
patients	patients	O	O
that	that	O	O
underwent	underwent	O	O
TEE	tee	O	O
with	with	O	O
MZ	mz	S_chemical	O
associated	associated	O	O
to	to	O	O
moderate	moderate	O	O
sedation	sedation	O	O
.	.	O	O

We	we	O	O
analyzed	analyzed	O	O
the	the	O	O
following	following	O	O
events	events	O	O
:	:	O	O
complications	complications	O	O
related	related	O	O
with	with	O	O
the	the	O	O
topical	topical	O	O
anesthesia	anesthesia	O	O
,	,	O	O
with	with	O	O
MZ	mz	S_chemical	O
use	use	O	O
and	and	O	O
with	with	O	O
the	the	O	O
procedure	procedure	O	O
.	.	O	O

Uni-	uni-	S_chemical	O
and	and	O	O
multivariate	multivariate	O	O
analyses	analyses	O	O
were	were	O	O
used	used	O	O
to	to	O	O
test	test	O	O
the	the	O	O
influence	influence	O	O
of	of	O	O
the	the	O	O
clinical	clinical	O	O
variables	variables	O	O
:	:	O	O
age	age	O	O
,	,	O	O
sex	sex	O	O
,	,	O	O
stroke	stroke	O	S_disease
,	,	O	O
myocardiopathy	myocardiopathy	O	O
(	(	O	O
MP	mp	O	O
)	)	O	O
,	,	O	O
duration	duration	O	O
of	of	O	O
the	the	O	O
test	test	O	O
,	,	O	O
mitral	mitral	O	B_disease
regurgitation	regurgitation	O	I_disease
(	(	O	O
MR	mr	O	S_disease
)	)	O	O
and	and	O	O
the	the	O	O
MZ	mz	S_chemical	O
dose	dose	O	O
.	.	O	O

RESULTS	results	O	O
:	:	O	O
All	all	O	O
patients	patients	O	O
(	(	O	O
65+/-16	65+/-16	O	O
yrs	yrs	O	O
;	;	O	O
58	58	O	O
%	%	O	O
males	males	O	O
)	)	O	O
finished	finished	O	O
the	the	O	O
examination	examination	O	O
.	.	O	O

The	the	O	O
mean	mean	O	O
doses	doses	O	O
of	of	O	O
MZ	mz	S_chemical	O
and	and	O	O
FL	fl	O	O
were	were	O	O
4.3+/-1.9	4.3+/-1.9	O	O
mg	mg	O	O
and	and	O	O
0.28+/-0.2	0.28+/-0.2	O	O
mg	mg	O	O
,	,	O	O
respectively	respectively	O	O
.	.	O	O

The	the	O	O
duration	duration	O	O
of	of	O	O
the	the	O	O
examination	examination	O	O
and	and	O	O
the	the	O	O
mean	mean	O	O
ejection	ejection	O	O
fraction	fraction	O	O
(	(	O	O
EF	ef	O	O
)	)	O	O
were	were	O	O
16.4+/-6.1	16.4+/-6.1	O	O
minutes	minutes	O	O
and	and	O	O
60+/-9	60+/-9	O	O
%	%	O	O
,	,	O	O
respectively	respectively	O	O
.	.	O	O

Mild	mild	O	O
hypoxia	hypoxia	O	S_disease
(	(	O	O
SO2<90	so2<90	O	O
%	%	O	O
)	)	O	O
was	was	O	O
the	the	O	O
most	most	O	O
common	common	O	O
event	event	O	O
(	(	O	O
11	11	O	O
patients	patients	O	O
)	)	O	O
;	;	O	O
3	3	O	O
patients	patients	O	O
(	(	O	O
2	2	O	O
%	%	O	O
)	)	O	O
presented	presented	O	O
transient	transient	O	O
hypoxia	hypoxia	O	S_disease
due	due	O	O
to	to	O	O
upper	upper	O	B_disease
airway	airway	O	B_disease
obstruction	obstruction	O	I_disease
by	by	O	O
probe	probe	O	O
introduction	introduction	O	O
and	and	O	O
8	8	O	O
(	(	O	O
5.8	5.8	O	O
%	%	O	O
)	)	O	O
due	due	O	O
to	to	O	O
hypoxia	hypoxia	O	S_disease
caused	caused	O	O
by	by	O	O
MZ	mz	S_chemical	O
use	use	O	O
.	.	O	O

Transient	transient	O	O
hypotension	hypotension	O	S_disease
(	(	O	O
SAP<90mmHg	sap<90mmhg	O	O
)	)	O	O
occurred	occurred	O	O
in	in	O	O
1	1	O	O
patient	patient	O	O
(	(	O	O
0.7	0.7	O	O
%	%	O	O
)	)	O	O
.	.	O	O

The	the	O	O
multivariate	multivariate	O	O
analysis	analysis	O	O
showed	showed	O	O
that	that	O	O
severe	severe	O	O
MR	mr	O	S_disease
,	,	O	O
MP	mp	O	O
(	(	O	O
EF<45	ef<45	O	O
%	%	O	O
)	)	O	O
and	and	O	O
high	high	O	O
doses	doses	O	O
of	of	O	O
MZ	mz	S_chemical	O
(	(	O	O
>	>	O	O
5	5	O	O
mg	mg	O	O
)	)	O	O
were	were	O	O
associated	associated	O	B_disease
with	with	O	I_disease
events	events	O	O
(	(	O	O
p<0.001	p<0.001	O	O
)	)	O	O
.	.	O	O

The	the	O	O
EF	ef	O	O
was	was	O	O
40	40	O	O
%	%	O	O
,	,	O	O
in	in	O	O
the	the	O	O
group	group	O	O
with	with	O	O
MP	mp	O	O
and	and	O	O
44	44	O	O
%	%	O	O
in	in	O	O
the	the	O	O
group	group	O	O
with	with	O	O
severe	severe	O	O
MR	mr	O	S_disease
and	and	O	O
it	it	O	O
can	can	O	O
be	be	O	O
a	a	O	O
factor	factor	O	O
associated	associated	O	B_disease
with	with	O	I_disease
clinical	clinical	O	O
events	events	O	O
in	in	O	O
the	the	O	O
last	last	O	O
group	group	O	O
.	.	O	O

CONCLUSION	conclusion	O	O
:	:	O	O
TEE	tee	O	O
with	with	O	O
sedation	sedation	O	O
presents	presents	O	O
a	a	O	O
low	low	O	O
rate	rate	O	O
of	of	O	O
events	events	O	O
.	.	O	O

There	there	O	O
were	were	O	O
no	no	O	O
severe	severe	O	O
events	events	O	O
and	and	O	O
there	there	O	O
was	was	O	O
no	no	O	O
need	need	O	O
to	to	O	O
interrupt	interrupt	O	O
the	the	O	O
examinations	examinations	O	O
.	.	O	O

